Skip to main content

The Deal Sheet!

About the company

Adlore is designing the next generation device for the treatment of lower extremity difficult to heal wounds, i.e. diabetic/neuropathic foot ulcers, venous stasis leg wounds, arterial and ischemic ulcers.  This device will incorporate Adlore’s proprietary SenLore™ technology to improve healing rates by supplying heat, thermo-regulated electrical pulse stimulation to increase blood flow, and a feedback sensor to monitor performance.  The performance information will be communicated to the patient via a proprietary APP and via Wi-Fi to the clinician.  The Adlore device will change how wounds are treated, improve patient well-being, and reduce health care costs.

Transaction Details

Investment Fund:
Birmingham Angels
$$ Committed:
Seed / Pre- Revenue
Convertible Note

Have a deal to pitch us?

Please apply here